LANSING, Mich., May 1, 2012 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB.PK) (the "Company") announces that the Company exhibited its Monster Silk™ technology at the recently concluded Techtextil North America conference in Atlanta, Georgia. The Company's exhibit, which featured living transgenic silkworms, Monster Silk™ cocoons, spools of recombinant spider silk and the Company's CEO, was the first exhibition of recombinant spider silk technology to the greater technical textile community. The Company used the event as a mass networking venue to promote its Monster Silk(TM) technology to textile industry experts, corporations and governmental professionals.
"In most cases we were introducing technical textile companies to our spider silk technology," said CEO Kim K Thompson. "But many attendees had been following our development of Monster Silk™ and sought us out when they learned we would be exhibiting.
"Techtextil North America exceeded our expectations and goals in terms of the overwhelmingly positive response we received from industry representatives," continued Thompson. "Numerous attendees expressed outright amazement at our recombinant spider silk technology."
"One of our key conference objectives was to meet with representatives of a number of specific companies who we had long targeted as potential Monster Silk™ commercialization partners. The Techtextil conference actually exceeded our expectations in that regard as well, as we were able to meet with most of those companies, along with representatives of a great many other companies in the technical textile industry. We're most pleased with these initial meetings and with the reception that the conference attendees gave our recombinant spider silk. Of course we are only looking for a very limited number of companies to act as commercialization partners for recombinant spider silk based products. We want to thank the Techtextil organizers as well as all of the conference attendees who made our debut a resounding success."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (http://www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
CONTACT: Ben Hansel Hansel Capital firstname.lastname@example.org (720) 288-8495